Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome

Background. Toxic shock syndrome is a potentially fatal toxin-mediated disease. The role of toxins in this clinical entity made us hypothesize that extracorporeal blood purification with CytoSorb® could play a beneficial role in the clinical management of toxic shock syndrome. This case report descr...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Berkes, Edit Szikszay, János Kappelmayer, Adrienne Kerényi, Tamás Szabó, László Ujhelyi, Krisztina Bari, György Balla, József Balla
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Critical Care
Online Access:http://dx.doi.org/10.1155/2017/3818407
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565388717588480
author Andrea Berkes
Edit Szikszay
János Kappelmayer
Adrienne Kerényi
Tamás Szabó
László Ujhelyi
Krisztina Bari
György Balla
József Balla
author_facet Andrea Berkes
Edit Szikszay
János Kappelmayer
Adrienne Kerényi
Tamás Szabó
László Ujhelyi
Krisztina Bari
György Balla
József Balla
author_sort Andrea Berkes
collection DOAJ
description Background. Toxic shock syndrome is a potentially fatal toxin-mediated disease. The role of toxins in this clinical entity made us hypothesize that extracorporeal blood purification with CytoSorb® could play a beneficial role in the clinical management of toxic shock syndrome. This case report describes the successful treatment of toxic shock syndrome using a combination of renal replacement therapy and hemadsorption in a pediatric patient. Case Presentation. A 5-year-old girl with Down’s syndrome presented with an inflamed area surrounding an insect bite, signs of systemic inflammation, and multiple organ failure. As previous attempts of immune modulation therapy were unsuccessful, renal replacement therapy was supplemented by the cytokine absorber CytoSorb. Treatment using this combination was associated with a rapid and significant stabilization in the hemodynamic situation and a decrease in inflammatory mediators within hours after the initiation of therapy. The application of CytoSorb therapy was simple and safe. Conclusion. The use of extracorporeal blood purification with CytoSorb proved potentially beneficial by removing toxins and inflammatory mediators in this case and could therefore play a role in the clinical management of toxic shock syndrome. Whether CytoSorb has the potential to even positively influence mortality in patients with toxic shock syndrome still needs to be confirmed.
format Article
id doaj-art-6ec0dd4bf6db477f8d8306a7350124fb
institution Kabale University
issn 2090-6420
2090-6439
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Critical Care
spelling doaj-art-6ec0dd4bf6db477f8d8306a7350124fb2025-02-03T01:07:51ZengWileyCase Reports in Critical Care2090-64202090-64392017-01-01201710.1155/2017/38184073818407Use of Hemadsorption in a Case of Pediatric Toxic Shock SyndromeAndrea Berkes0Edit Szikszay1János Kappelmayer2Adrienne Kerényi3Tamás Szabó4László Ujhelyi5Krisztina Bari6György Balla7József Balla8Department of Pediatrics, University of Debrecen, Debrecen 4012, HungaryDepartment of Pediatrics, University of Debrecen, Debrecen 4012, HungaryInstitute of Laboratory Medicine, University of Debrecen, Debrecen 4012, HungaryInstitute of Laboratory Medicine, University of Debrecen, Debrecen 4012, HungaryDepartment of Pediatrics, University of Debrecen, Debrecen 4012, HungaryDepartment of Medicine, Faculty of Medicine, University of Debrecen, Debrecen 4012, HungaryFresenius Medical Care, NephroCare University of Debrecen, Debrecen 4012, HungaryDepartment of Pediatrics, University of Debrecen, Debrecen 4012, HungaryDepartment of Medicine, Faculty of Medicine, University of Debrecen, Debrecen 4012, HungaryBackground. Toxic shock syndrome is a potentially fatal toxin-mediated disease. The role of toxins in this clinical entity made us hypothesize that extracorporeal blood purification with CytoSorb® could play a beneficial role in the clinical management of toxic shock syndrome. This case report describes the successful treatment of toxic shock syndrome using a combination of renal replacement therapy and hemadsorption in a pediatric patient. Case Presentation. A 5-year-old girl with Down’s syndrome presented with an inflamed area surrounding an insect bite, signs of systemic inflammation, and multiple organ failure. As previous attempts of immune modulation therapy were unsuccessful, renal replacement therapy was supplemented by the cytokine absorber CytoSorb. Treatment using this combination was associated with a rapid and significant stabilization in the hemodynamic situation and a decrease in inflammatory mediators within hours after the initiation of therapy. The application of CytoSorb therapy was simple and safe. Conclusion. The use of extracorporeal blood purification with CytoSorb proved potentially beneficial by removing toxins and inflammatory mediators in this case and could therefore play a role in the clinical management of toxic shock syndrome. Whether CytoSorb has the potential to even positively influence mortality in patients with toxic shock syndrome still needs to be confirmed.http://dx.doi.org/10.1155/2017/3818407
spellingShingle Andrea Berkes
Edit Szikszay
János Kappelmayer
Adrienne Kerényi
Tamás Szabó
László Ujhelyi
Krisztina Bari
György Balla
József Balla
Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome
Case Reports in Critical Care
title Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome
title_full Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome
title_fullStr Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome
title_full_unstemmed Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome
title_short Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome
title_sort use of hemadsorption in a case of pediatric toxic shock syndrome
url http://dx.doi.org/10.1155/2017/3818407
work_keys_str_mv AT andreaberkes useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT editszikszay useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT janoskappelmayer useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT adriennekerenyi useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT tamasszabo useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT laszloujhelyi useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT krisztinabari useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT gyorgyballa useofhemadsorptioninacaseofpediatrictoxicshocksyndrome
AT jozsefballa useofhemadsorptioninacaseofpediatrictoxicshocksyndrome